Macquarie University-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy

    Bioengineering and Translational Medicine, Vol. 8, Núm. 1

2022

  1. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy

    Seminars in Cancer Biology, Vol. 86, pp. 396-419

  2. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance

    Expert Opinion on Drug Delivery, Vol. 19, Núm. 4, pp. 355-382

  3. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

    npj Parkinson's Disease, Vol. 8, Núm. 1

  4. Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology

    Nano Today, Vol. 45

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

    Parkinsonism and Related Disorders, Vol. 62, pp. 201-209

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222